A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study

Baseline clinical prognostic factors for recurrent and/or metastatic (RM) head and neck squamous cell carcinoma (HNSCC) treated with immunotherapy are lacking. CT-based radiomics may provide additional prognostic information. A total of 85 patients with RM-HNSCC were enrolled for this study. For eac...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diagnostics (Basel)
Auteurs principaux: Corino, Valentina D. A., Bologna, Marco, Calareso, Giuseppina, Licitra, Lisa, Ghi, Mariagrazia, Rinaldi, Gaetana, Caponigro, Francesco, Morelli, Franco, Airoldi, Mario, Allegrini, Giacomo, Cassano, Alessandra, Ferrari, Daris, Mirabile, Aurora, Tosoni, Alicia, Galizia, Danilo, Merlano, Marco, Sponghini, Andrea, Moretti, Gabriella, Mainardi, Luca, Bossi, Paolo
Format: Artigo
Langue:Inglês
Publié: MDPI 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8229740/
https://ncbi.nlm.nih.gov/pubmed/34071518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11060979
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires